Dendritic cell vaccination and immune monitoring

被引：0

作者：

E. H. J. G. Aarntzen

C. G. Figdor

G. J. Adema

C. J. A. Punt

I. J. M. de Vries

机构：

[1] Nijmegen Centre for Molecular Life Sciences,Department of Medical Oncology

[2] Radboud University Nijmegen Medical Centre,Department of Tumor Immunology

[3] Nijmegen Centre for Molecular Life Sciences,Department of Pediatric Hemato

[4] Radboud University Nijmegen Medical Centre,Oncology

[5] Nijmegen Centre for Molecular Life Sciences,undefined

[6] Radboud University Nijmegen Medical Centre,undefined

来源：

Cancer Immunology, Immunotherapy | 2008年 / 57卷

关键词：

Dendritic cells; Specific immune responses; Migration; mRNA transfection; In vivo targeting;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We exploited dendritic cells (DC) to vaccinate melanoma patients. We recently demonstrated a statistical significant correlation between favorable clinical outcome and the presence of vaccine-related tumor antigen-specific T cells in delayed type hypersensitivity (DTH) skin biopsies. However, favorable clinical outcome is only observed in a minority of the treated patients. Therefore, it is obvious that current DC-based protocols need to be improved. For this reason, we study in small proof of principle trials the fate, interactions and effectiveness of the injected DC.

引用

页码：1559 / 1568

页数：9

共 50 条

[41] Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide
Höltl, L
Ramoner, R
Zelle-Rieser, C
Gander, H
Putz, T
Papesh, C
Nussbaumer, W
Falkensammer, C
Bartsch, G
Thurnher, M
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (07) : 663 - 670
[42] Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide
Lorenz Höltl
Reinhold Ramoner
Claudia Zelle-Rieser
Hubert Gander
Thomas Putz
Christine Papesh
Walter Nussbaumer
Claudia Falkensammer
Georg Bartsch
Martin Thurnher
Cancer Immunology, Immunotherapy, 2005, 54 : 663 - 670
[43] Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma
Leonhartsberger, Nicolai
Ramoner, Reinhold
Falkensammer, Claudia
Rahm, Andrea
Gander, Hubert
Hoeltl, Lorenz
Thurnher, Martin
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (09) : 1407 - 1413
[44] Dendritic-cell- and peptide-based vaccination strategies for glioma
Yamanaka, Ryuya
NEUROSURGICAL REVIEW, 2009, 32 (03) : 265 - 273
[45] Dendritic/tumor fusion cell-based vaccination against cancer
Koido, Shigeo
Hara, Eiichi
Homma, Sadarnu
Fujise, Kiyotaka
Gong, Jianlin
Tajiri, Hisao
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2007, 55 (05) : 281 - 287
[46] Dendritic-cell- and peptide-based vaccination strategies for glioma
Ryuya Yamanaka
Neurosurgical Review, 2009, 32 : 265 - 273
[47] Dendritic cell vaccination in glioblastoma after fluorescence-guided resection
Diez Valle, Ricardo
Lopez-Diaz de Cerio, Ascension
Inoges, Susana
Tejada, Sonia
Pastor, Fernando
Villanueva, Helena
Gallego, Jaime
Espinos, Jaime
Aristu, Javier
Angel Idoate, Miguel
Andreu, Enrique
Bendandi, Maurizio
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2012, 3 (11): : 142 - 149
[48] Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation
Perruccio, K
Bozza, S
Montagnoli, C
Bellocchio, S
Aversa, F
Martelli, M
Bistoni, F
Velardi, A
Romani, L
BLOOD CELLS MOLECULES AND DISEASES, 2004, 33 (03) : 248 - 255
[49] Current State and Prospects of Using Dendritic Cell Vaccination for Cancer Immunotherapy
Filin, I. Yu.
Kitaeva, K. V.
Rizvanov, A. A.
Solovyeva, V. V.
UCHENYE ZAPISKI KAZANSKOGO UNIVERSITETA-SERIYA ESTESTVENNYE NAUKI, 2022, 164 (03): : 347 - 366
[50] Dendritic/tumor fusion cell-based vaccination against cancer
Shigeo Koido
Eiichi Hara
Sadamu Homma
Kiyotaka Fujise
Jianlin Gong
Hisao Tajiri
Archivum Immunologiae et Therapiae Experimentalis, 2007, 55 : 281 - 287

← 1 2 3 4 5 →